Stryker PE Ratio 2012-2025 | SYK
Current and historical p/e ratio for Stryker (SYK) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Stryker PE ratio as of January 22, 2026 is 27.23.
| Stryker PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-23 | 355.04 | 46.65 | |
| 2025-09-30 | 368.75 | $7.61 | 48.46 |
| 2025-06-30 | 393.75 | $7.55 | 52.15 |
| 2025-03-31 | 369.69 | $7.40 | 49.96 |
| 2024-12-31 | 356.75 | $7.76 | 45.97 |
| 2024-09-30 | 357.12 | $9.33 | 38.28 |
| 2024-06-30 | 335.60 | $8.97 | 37.41 |
| 2024-03-31 | 352.15 | $8.76 | 40.20 |
| 2023-12-31 | 294.00 | $8.25 | 35.64 |
| 2023-09-30 | 267.57 | $6.74 | 39.70 |
| 2023-06-30 | 297.89 | $7.08 | 42.07 |
| 2023-03-31 | 278.04 | $6.87 | 40.47 |
| 2022-12-31 | 237.48 | $6.17 | 38.49 |
| 2022-09-30 | 196.13 | $6.43 | 30.50 |
| 2022-06-30 | 191.98 | $5.43 | 35.36 |
| 2022-03-31 | 257.10 | $5.26 | 48.88 |
| 2021-12-31 | 256.51 | $5.21 | 49.23 |
| 2021-09-30 | 252.32 | $4.97 | 50.77 |
| 2021-06-30 | 247.92 | $5.46 | 45.41 |
| 2021-03-31 | 231.94 | $3.69 | 62.86 |
| 2020-12-31 | 232.72 | $4.20 | 55.41 |
| 2020-09-30 | 197.38 | $4.61 | 42.81 |
| 2020-06-30 | 170.21 | $4.21 | 40.43 |
| 2020-03-31 | 156.75 | $5.69 | 27.55 |
| 2019-12-31 | 196.94 | $5.48 | 35.94 |
| 2019-09-30 | 202.35 | $9.02 | 22.43 |
| 2019-06-30 | 191.86 | $9.34 | 20.54 |
| 2019-03-31 | 183.87 | $9.27 | 19.83 |
| 2018-12-31 | 145.53 | $9.34 | 15.58 |
| 2018-09-30 | 164.40 | $3.24 | 50.74 |
| 2018-06-30 | 155.83 | $2.83 | 55.06 |
| 2018-03-31 | 148.09 | $2.67 | 55.46 |
| 2017-12-31 | 142.07 | $2.68 | 53.01 |
| 2017-09-30 | 129.91 | $4.68 | 27.76 |
| 2017-06-30 | 126.57 | $4.48 | 28.25 |
| 2017-03-31 | 119.70 | $4.45 | 26.90 |
| 2016-12-31 | 108.58 | $4.35 | 24.96 |
| 2016-09-30 | 105.13 | $4.39 | 23.95 |
| 2016-06-30 | 107.87 | $4.24 | 25.44 |
| 2016-03-31 | 96.26 | $4.27 | 22.54 |
| 2015-12-31 | 83.09 | $3.78 | 21.98 |
| 2015-09-30 | 83.78 | $3.07 | 27.29 |
| 2015-06-30 | 84.79 | $2.44 | 34.75 |
| 2015-03-31 | 81.55 | $1.97 | 41.40 |
| 2014-12-31 | 83.07 | $1.57 | 52.91 |
| 2014-09-30 | 70.86 | $1.91 | 37.10 |
| 2014-06-30 | 73.71 | $2.02 | 36.49 |
| 2014-03-31 | 70.97 | $2.02 | 35.13 |
| 2013-12-31 | 65.20 | $2.63 | 24.79 |
| 2013-09-30 | 58.41 | $2.33 | 25.07 |
| 2013-06-30 | 55.68 | $2.98 | 18.69 |
| 2013-03-31 | 55.94 | $3.27 | 17.11 |
| 2012-12-31 | 46.81 | $3.39 | 13.81 |
| 2012-09-30 | 47.30 | $3.73 | 12.68 |
| 2012-06-30 | 46.65 | $3.65 | 12.78 |
| 2012-03-31 | 46.78 | $3.59 | 13.03 |
| 2011-12-31 | 41.75 | $3.46 | 12.07 |
| 2011-09-30 | 39.42 | $3.15 | 12.51 |
| 2011-06-30 | 48.91 | $3.16 | 15.48 |
| 2011-03-31 | 50.51 | $3.17 | 15.93 |
| 2010-12-31 | 44.48 | $3.19 | 13.94 |
| 2010-09-30 | 41.32 | $3.21 | 12.87 |
| 2010-06-30 | 41.20 | $2.93 | 14.06 |
| 2010-03-31 | 46.95 | $2.86 | 16.42 |
| 2009-12-31 | 41.22 | $2.77 | 14.88 |
| 2009-09-30 | 37.00 | $2.70 | 13.70 |
| 2009-06-30 | 32.36 | $2.79 | 11.60 |
| 2009-03-31 | 27.72 | $2.79 | 9.94 |
| 2008-12-31 | 32.53 | $2.78 | 11.70 |
| 2008-09-30 | 50.22 | $2.75 | 18.26 |
| 2008-06-30 | 50.69 | $2.64 | 19.20 |
| 2008-03-31 | 52.44 | $2.56 | 20.48 |
| 2007-12-31 | 60.24 | $2.44 | 24.69 |
| 2007-09-30 | 55.19 | $2.33 | 23.69 |
| 2007-06-30 | 50.64 | $2.24 | 22.61 |
| 2007-03-31 | 53.23 | $2.11 | 25.23 |
| 2006-12-31 | 44.24 | $1.89 | 23.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $137.164B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.859B | 21.09 |
| EssilorLuxottica (ESLOY) | France | $145.490B | 0.00 |
| Boston Scientific (BSX) | United States | $135.332B | 30.95 |
| Medtronic (MDT) | Ireland | $129.919B | 18.00 |
| Medline (MDLN) | United States | $60.378B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.195B | 0.00 |
| Agilent Technologies (A) | United States | $39.301B | 24.84 |
| GE HealthCare Technologies (GEHC) | United States | $37.303B | 17.84 |
| ResMed (RMD) | United States | $37.266B | 25.79 |
| Koninklijke Philips (PHG) | Netherlands | $28.637B | 18.70 |
| Terumo (TRUMY) | Japan | $20.358B | 22.92 |
| Insulet (PODD) | United States | $19.697B | 61.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.349B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.055B | 0.00 |
| Baxter (BAX) | United States | $10.317B | 8.33 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.233B | 29.60 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.455B | 13.57 |
| BillionToOne (BLLN) | United States | $4.145B | 0.00 |
| Envista Holdings (NVST) | United States | $4.014B | 23.03 |
| ICU Medical (ICUI) | United States | $3.914B | 24.85 |
| Haemonetics (HAE) | United States | $3.278B | 14.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.257B | 14.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.159B | 47.26 |
| QuidelOrtho (QDEL) | United States | $2.076B | 13.35 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $1.990B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.945B | 39.15 |
| Curaleaf Holdings (CURLF) | Canada | $1.764B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.687B | 16.85 |
| Green Thumb Industries (GTBIF) | United States | $1.649B | 72.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.442B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.422B | 20.59 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.390B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.251B | 371.14 |
| Capricor Therapeutics (CAPR) | United States | $1.105B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.064B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.890B | 10.06 |
| Valneva SE (VALN) | France | $0.886B | 0.00 |
| Omeros (OMER) | United States | $0.861B | 0.00 |
| CeriBell (CBLL) | United States | $0.842B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.602B | 16.32 |
| Verano Holdings (VRNO) | United States | $0.516B | 0.00 |
| Cerus (CERS) | United States | $0.503B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.431B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.337B | 0.00 |
| Evolus (EOLS) | United States | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.282B | 22.51 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 144.33 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.235B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.199B | 17.54 |
| Sanara MedTech (SMTI) | United States | $0.198B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.195B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.183B | 0.00 |
| Accendra Health (ACH) | United States | $0.163B | 1.64 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.132B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.56 |
| Sharps Technology (STSS) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.23 |
| Nephros (NEPH) | United States | $0.050B | 35.85 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.27 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |